JUMPCAN(SH:600566) Zheng Quan Ri Bao·2025-11-25 11:40Core Viewpoint - Jichuan Pharmaceutical has won a bid for its product Ibuprofen Suspension in a centralized procurement process in Guangdong, which is expected to increase the product's market volume in the awarded regions. However, this product is not a core offering for the company, and its impact on overall operations is limited [2]. Group 1 - The company stated that it will closely monitor developments related to centralized procurement and actively respond to the opportunities and challenges it presents [2]. - The company plans to consolidate and expand its existing market share through multiple channels [2]. - The company aims to enrich its product line and enhance business stability by pursuing both external acquisitions and internal research and development for new products [2].